Pharmacoproteomic characterisation of human colon and rectal cancer

Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of > 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Frejno, Martin, Zenezini Chiozzi, Riccardo, Wilhelm, Mathias, Koch, Heiner, Zheng, Runsheng, Klaeger, Susan, Ruprecht, Benjamin, Meng, Chen, Kramer, Karl, Jarzab, Anna, Heinzlmeir, Stephanie, Johnstone, Elaine, Domingo, Enric, Kerr, David, Jesinghaus, Moritz, Slotta‐Huspenina, Julia, Weichert, Wilko, Knapp, Stefan, Feller, Stephan M, Kuster, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731344/
https://www.ncbi.nlm.nih.gov/pubmed/29101300
http://dx.doi.org/10.15252/msb.20177701